Coronavirus channel feed – Endpoints News

Coronavirus channel feed

Manufacturing problems trigger another clinical hold for troubled Covid-19 vaccine — latest in a string of roadblocks

4 years ago

Covid-19 roundup: Gavi raises $4.8B in pledged funds; Japan cancels order of 40M remaining AstraZeneca shots

4 years ago

Another lot of Moderna's Rovi-made Spikevax recalled after particulate found in vial

4 years ago

Europe holds off on a fourth Covid vaccine shot for those under the age of 80

4 years ago

FDA's court-mandated release of Pfizer Covid-19 vaccine documents continues to turn over few surprises

4 years ago

FDA halts the use of GSK's Covid-19 drug completely as BA.2 subvariant blankets the country

4 years ago

Covid-19 roundup: Congress agrees to $10B spending bill; New preprint shows Gilead's Veklury is ineffective

4 years ago

FDA convenes committee of vaccine experts to consider a flu-like path for Omicron-specific boosters

4 years ago

Covid-19 roundup: FDA grants priority review to Roche's Actemra; WHO suspends UN supply of Covaxin — report

4 years ago

FDA cuts off use of GSK's Covid treatment in almost half of the US as BA.2 spreads

4 years ago

Covid-19 roundup: Congress reportedly nearing $10B funding deal; Merck and Ridgeback tout new molnupiravir data

4 years ago

Cancer drug developers will learn from the blazing speed of the Covid-19 vaccine race, FDA leaders say

4 years ago

Peter Hotez and Maria Bottazzi's 'forgotten' vaccine approved in Botswana

4 years ago

Covid-19 roundup: CureVac, GSK debut second shot at pandemic vaccine; BioNTech expands Covid-19 trial

4 years ago

Adagio presses forward with their FDA pitch for Covid antibody — despite Omicron flaws

4 years ago

Without an adcomm, FDA signs off on second Covid-19 booster for those over 50

4 years ago

Researchers point to a host-directed Covid-19 antiviral that could be combined with existing pandemic treatments

4 years ago

US halts use of GSK/Vir monoclonal in 8 states as FDA says it can't defeat new Omicron subvariant

4 years ago

Big Pharma has skirted long Covid, but a pipeline of small biotechs is testing treatments for lingering symptoms

4 years ago

A biotech developing a synthetic biology Covid-19 vaccine comes up short in first data readout — and investors are fleeing

4 years ago

Moderna preps for a private, more expensive Covid-19 vaccine market as Biden admin frets over unintentional shift

4 years ago

Moderna hits primary endpoint in Covid vax trial for youngest kids, but efficacy tops out at under 45%

4 years ago

Seattle-based Covid-19 vaccine developer seeks $950M from Indian partner over trade secret theft

4 years ago

In year 3 of the pandemic, a new Covid-19 biotech takes flight with an antibody combo and Takeda's ex-vaccines chief at the helm

4 years ago

First page Previous page 10 11 121314 15 16 Next page Last page